CLINICAL_TRIALS
trial_result
· 2016-07-27
Clinical Trial Update: An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+ [Phase 2]
Summary
Phase 2 trial evaluating a Listeria monocytogenes-based vaccine for cervical intraepithelial neoplasia (CIN 2+) was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Advaxis, Inc. | Conditions: Cervical Intraepithelial Neoplasia | Phase 2 | Status: TERMINATED